Esophagus : official journal of the Japan Esophageal SocietyHumansEsophageal NeoplasmsMaleFemaleMiddle Aged
Safety and efficacy of conversion therapy for metastatic esophageal cancer: exploratory analysis of JCOG1314.
Satoru Matsuda, Takahiro Tsushima, Hirofumi Kawakubo, Shuichi Hironaka, Yasuhiro Tsubosa, Katsuyuki Sakanaka, Junya Oguma, Shigenori Kadowaki, Shigeru Tsunoda, Hiroki Hara, Kazuo Koyanagi, Toshifumi Yamaguchi, Kazuaki Harada, Masanobu Takahashi, Keiko Minashi
Published: 202610.1007/s10388-025-01163-2
Abstract
BACKGROUND: Recent advances in multimodal treatments indicate that conversion therapy (CT) is a viable option for metastatic esophageal cancer (EC). JCOG1314 was a randomized phase III trial to confirm the survival benefit of docetaxel plus cisplatin…
Preview only. Read the full abstract at the source